Haemophagocytic lymphohistiocytosis: An elusive syndrome

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 16, Issue 5, 2016, Pages 432-436

  Thomas, William ^a   Van't Veer, Mars ^a   Besser, Martin ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Haemophagocytic lymphohistiocytosis; Haemophagocytic syndrome; Macrophage activation syndrome

Indexed keywords

AMPHOTERICIN B; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

CANCER PROGNOSIS; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CRITERION VARIABLE; DISEASE CLASSIFICATION; ERYTHROCYTE SEDIMENTATION RATE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; LYMPHADENOPATHY; LYMPHOMA; MACROPHAGE; MACROPHAGE ACTIVATION SYNDROME; MOLECULAR DIAGNOSIS; NONHUMAN; OVERALL SURVIVAL; PANCYTOPENIA; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PYREXIA IDIOPATHICA; REVIEW; VISCERAL LEISHMANIASIS; DIFFERENTIAL DIAGNOSIS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PATHOLOGY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC;

EID: 85015052173     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.16-5-432     Document Type: Review

References (12)

1. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat haemophagocytic lymphohistiocytosis. Blood 2011;118:4041-52.
2. Lehmberg K, Ehl S. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol 2013;160:275-87.
3. Henter JI, Horne A, Arico M et al. HLH-2004: diagnostic and theraputic guidelines for haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
4. Cetica V, Pende D, Griffiths GM, Arico M. Molecular basis of familial hemophagocytic lymphohistiocytosis. Haematologica 2010;95:538-41.
5. Sieni E, Cetica V, Piccin A et al. Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series. PLoS One 2012;7:e44649.
6. Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic Factors and Outcomes of Adults With Hemophagocytic Lymphohistiocytosis. Mayo Clin Proc 2014;89:484-92.
7. Trottestam H, Horne A, Arico M. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long term results of the HLH-94 protocol. Blood 2011;118:4577-84.
8. Marsh RA, Vaughn G, Kim M et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 2010;116:5824-31.
9. Henter JI, Samuelsson-Horne A, Arico M et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367-73.
10. Imashuku S, Kuriyama K, Sakai R. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 2003;41:103-9.
11. Chellapandian D, Das R, Zelley K et al. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol 2013;162:376-82.
12. Hasselblom S, Linde A, Ridell B. Hodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome. J Intern Med 2004;255:289-95.